A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01)
Patent
CA 2595398
The present invention generally relates to a pharmaceutical composition and to an improved method of preventing, attenuating and treating multiple myeloma (MM) by administering to an individual in need thereof at least one antibody to fibroblast growth factor receptor 3 (FGFR3). In particular, the at least one FGR3 antibody induces apoptosis of myeloma cells expressing wild type FGFR3.
L'invention se rapporte de manière générale à une composition pharmaceutique et à une méthode améliorée permettant de prévenir, d'atténuer et de traiter le myélome multiple (MM) par l'administration à un individu nécessitant un tel traitement d'au moins un anticorps dirigé contre le récepteur du facteur croissance fibroblastique 3 (FGFR3). De manière plus particulière, ce(s) anticorps du FGFR3 provoquent l'apoptose des cellules de myélome exprimant un FGFR3 de type sauvage.
Rom Eran
Trudel Suzanne
Yayon Avner
Fibron Limited
Ridout & Maybee Llp
University Health Network
LandOfFree
Treatment of b-cell malignancies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of b-cell malignancies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of b-cell malignancies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1440754